Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2

Analysis 2.3. Comparison 2 ZIPRASIDONE versus CLOZAPINE, Outcome 3 Adverse effects: cardiac effects - QTc prolongation.

Review: Ziprasidone versus other atypical antipsychotics for schizophrenia

Comparison: 2 ZIPRASIDONE versus CLOZAPINE

Outcome: 3 Adverse effects: cardiac effects - QTc prolongation

graphic file with name emss-57806-t0131.jpg